(Hypertension. 1998;31:511.)
© 1998 American Heart Association, Inc.
Scientific Contributions |
From the Departments of Internal Medicine and Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, MO.
Correspondence to Andrew J. Lonigro, MD, Saint Louis University, School of Medicine. 1402 South Grand Blvd, St. Louis, MO 63104. E-mail Lonigro{at}slu.edu
Increased microvascular permeability, which occurs in conditions such as the adult respiratory distress syndrome and diabetes mellitus, is related to physicochemical alterations in the microvascular barrier. We postulate that, in part, capillary pericytes affect microvascular permeability via production of a vasoactive cytokine, viz, vascular endothelial growth factor (VEGF), also known as vascular permeability factor. The goal of the present study was to evaluate the effects of phorbol myristate acetate (PMA), a substance known to produce nonhydrostatic pulmonary edema in intact animals, on VEGF gene expression in pericyte cultures. Microvascular pericytes were isolated from bovine retinas using magnetic microspheres coated with 3G5 monoclonal antibody. Pericyte identity was confirmed both morphologically and by immunostaining for
-smooth muscle actin and 3G5 ganglioside. The cultured pericytes were stimulated with N
-nitro-L-arginine methyl ester (L-NAME, 1x10-4 mmol/L), angiotensin II (1x10-6 mmol/L), and PMA (5x10-8 mmol/L), selected because of their ability to upregulate VEGF mRNA expressions in other cell types. Northern blot analysis was performed using [32P]dCTP labeled human VEGF cDNA (Genentech). Lane-loading differences were normalized using mouse GAPDH control cDNA probe. VEGF mRNA expression was upregulated by PMA (10-9 to 10-6 mol/L) in a dose-dependent manner, whereas neither L-NAME nor angiotensin II affected VEGF mRNA expression in pericytes. These results support the hypothesis that pericytes increase permeability of the endothelial barrier through increased VEGF production.
Key Words: pericytes vascular endothelial growth factor microvascular permeability phorbol myristate acetate 3G5 monoclonal antibody
Abbreviations: Ang II = angiotensin II L-NAME = N
-nitro-L-arginine methyl ester PMA = phorbol myristate acetate VEGF = vascular endothelial growth factor
This article has been cited by other articles:
![]() |
S. I. Resto-Ruiz, M. Schmiederer, D. Sweger, C. Newton, T. W. Klein, H. Friedman, and B. E. Anderson Induction of a Potential Paracrine Angiogenic Loop between Human THP-1 Macrophages and Human Microvascular Endothelial Cells during Bartonella henselae Infection Infect. Immun., August 1, 2002; 70(8): 4564 - 4570. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Morikawa, P. Baluk, T. Kaidoh, A. Haskell, R. K. Jain, and D. M. McDonald Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors Am. J. Pathol., March 1, 2002; 160(3): 985 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nadal, G. M. Scicli, L. A. Carbini, and A. G. Scicli Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H739 - H748. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Otani, H. Takagi, H. Oh, K. Suzuma, M. Matsumura, E. Ikeda, and Y. Honda Angiotensin II-Stimulated Vascular Endothelial Growth Factor Expression in Bovine Retinal Pericytes Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1192 - 1199. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |